of more than 32 million vaccine recipients in England showed that people given the AstraZeneca
vaccine were at a slightly increased risk of an extremely
rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), The New
York Times reports. Although, researchers said the risk of the disorder
is smaller than COVID-19 itself. U.K. drug regulators added the disorder
as a potential side effect of the AstraZeneca vaccine last week.